 
                    GO Report
| ID | GO:0010467 | 
|---|---|
| Name | gene expression | 
| Type | biological process | 
| No. of Genes in PTSDgene | 16 | 
| Approved Symbol | Approved Name | Location | Type | No. of Association Studies (Positive/Negative/Trend)  | Evidence[PMID] | 
|---|---|---|---|---|---|
| RPS29 | ribosomal protein S29 | 14q21.3 | Literature-origin | 1(0/0/1) | TAS | 
| TP53 | tumor protein p53 | 17p13.1 | rSNP target | 0 | TAS | 
| TEAD3 | TEA domain transcription factor 3 | 6p21.2 | Mapped by LD-proxy, rSNP target | 0 | TAS | 
| PSMA4 | proteasome subunit alpha 4 | 15q24.1 | Mapped by LD-proxy, rSNP target | 0 | TAS | 
| SMG8 | SMG8 nonsense mediated mRNA decay factor | 17q23.2 | rSNP target | 0 | TAS | 
| RPL10A | ribosomal protein L10a | 6p21.31 | rSNP target | 0 | TAS | 
| NR3C1 | nuclear receptor subfamily 3 group C member 1 | 5q31-q32 | Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target | 6(2/4/0) | TAS | 
| KAT2B | K(lysine) acetyltransferase 2B | 3p24 | Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy | 1(0/0/1) | TAS | 
| PRKCA | protein kinase C, alpha | 17q24.2 | Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy | 10(9/0/1) | TAS | 
| GARS | glycyl-tRNA synthetase | 7p15 | Mapped by LD-proxy, rSNP target | 0 | TAS | 
| PRPF31 | pre-mRNA processing factor 31 | 19q13.4 | Literature-origin | 1(0/0/1) | TAS | 
| RORA | RAR related orphan receptor A | 15q21-q22 | Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy | 6(4/2/0) | TAS | 
| JARID2 | jumonji and AT-rich interaction domain containing 2 | 6p24-p23 | rSNP target | 0 | TAS | 
| KIAA1456 | KIAA1456 | 8p22 | Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy | 1(0/0/1) | TAS | 
| RARS | arginyl-tRNA synthetase | 5q35.1 | rSNP target | 0 | TAS | 
| LTB | lymphotoxin beta | 6p21.3 | rSNP target | 0 | IEA | 
            Copyright: Key Lab of Mental Health, Institute of Psychology, Chinese Academy of Sciences Feedback
            
            Last update: April 1, 2018
            


